JOHN PETER MCLAUGHLIN Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN PETER MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN PETER MCLAUGHLIN. JOHN PETER MCLAUGHLIN is CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in PDL BIOPHARMA, INC. ($PDLI) and President, CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in ROCKWELL MEDICAL, INC. ($RMTI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Chief Executive Officer in ANESIVA, INC. ($CGTK) and President & CEO in ANESIVA, INC. ($CGTK) and Director in LENSAR, Inc. ($LNSR) and Director in Adverum Biotechnologies, Inc. ($AAVL).
JOHN PETER MCLAUGHLIN in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN PETER MCLAUGHLIN: Director
Holdings: 39,400 shares
Current Value: $2,395,126
Latest Transaction: May 24 2016
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN PETER MCLAUGHLIN in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, CGTK, LNSR, PDLI, RMTI, SGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 3,700 | 0 | 39,400 | 35.7 K to 39.4 K (+10.36 %) |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 3,700 | 0 | 35,700 | 32 K to 35.7 K (+11.56 %) |
Page: 1